Strategies for managing uncertainty in the pharmaceutical business
Webcode 26062201
Kristie Champlin Gurley
Covington & Burling LLP, Washington, DC
Kristie Gurley advises life sciences clients on complex pricing, reimbursement, and market access issues for drugs and biological products. She previously served in the Office of the General Counsel at the U.S. Department of Health and Human Services, where she was a lead attorney for implementation of the Inflation Reduction Act’s Medicare Drug Price Negotiation and Inflation Rebate Programs, as well as Medicaid Drug Rebate Program rulemaking and CMS innovation initiatives for cell and gene therapies. In private practice, she provides strategic, policy, and regulatory advice on federal health care program coverage and reimbursement, Medicaid price reporting, agency engagement, payer and value-based contracting, and broader commercial, compliance, litigation, and policy advocacy matters.
Dr. Dr. Adem Koyuncu
Law firm Covington & Burling LLP, Brussels & Frankfurt
Lawyer and Medical Doctor,
Partner in the Brussels and Frankfurt offices
More information please click here.
Dr. Sebastian Werner
vfa - Verband Forschender Arzneimittelhersteller e. V., Berlin
Dr Sebastian Werner is a Market Access and HTA Specialist at the vfa (German Association of Research-Based Pharmaceutical Companies) and serves there as an expert on benefit assessment and market access issues, with a focus on EU HTA. Previously, he worked, among other roles, in the drug assessment department at IQWiG and conducted research at the Max Planck Institute for Biological Cybernetics. He is a psychologist and a neuroscientist specialising in neuro- and behavioural sciences.
17/06/2026
17/06/2026
02:00 p.m. - 06:00 p.m.
online
online
Event - 890€ plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Event - 890€ plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Leila Dörfler
Team Leader Pharma & Healthcare
+49 6221 500-695
l.doerfler@forum-institut.de
Understand how the Most Favored Nation (MFN) principle is reshaping global pharmaceutical business. This compact online seminar helps you navigate pricing, discount models and market access uncertainty under current and emerging MFN approaches.
This live online seminar will equip you with a concise, practice-oriented update on the Most Favored Nation (MFN) principle in the global pharmaceutical business.
You will gain insights into current MFN-related developments in the USA and EU, including key discount models, pricing confidentiality and reference pricing, as well as their impact on launch sequencing, existing products and investment decisions from an innovative pharma perspective.
By attending this seminar, you will:
14:00 Welcome and introduction
14:20
Kristie Champlin Gurley
15:30 Coffee break
15:50
Dr. Dr. Adem Koyuncu
16:50 Coffee break
17:10
Dr. Sebastian Werner
18:00 Course end
You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.
We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.
of 5 stars of all ratings from 2025
of 5 stars on Trustpilot = good
This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital tra...
e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiation
This online event offers a comprehensive overview of marketing authorisation and market access in the Middle East, cover...
This seminar provides newcomers and career changers with a comprehensive introduction to European medical device regulat...
This course offers a deep dive into patient involvement in HTA processes across Europe, with a focus on the UK and Germa...
We provide flexible education and training with high-quality e-Learning programmes for several topics.
Details
Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.
Details
More than 3,700 customers have rated our training courses. Thank you for awarding us 4.4 stars out of 5.
Details
